Gyon Technologies Capital Management, LP Vertex Pharmaceuticals Inc Transaction History

Gyon Technologies Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $1.81 Million - $2.04 Million	6,333 New	6,333 $1.83 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $59,679 - $74,307	254 Added 7.17%	3,797 $1.07 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $784,491 - $924,616	3,543 New	3,543 $925,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $376,166 - $466,626	-1,883 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $313,914 - $421,622	1,883 New	1,883 $412,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.